These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 33429408)

  • 1. Lyumjev - a new insulin lispro for diabetes.
    Med Lett Drugs Ther; 2020 Oct; 62(1609):162-163. PubMed ID: 33429408
    [No Abstract]   [Full Text] [Related]  

  • 2. In brief: Another insulin lispro (Admelog) for diabetes.
    Med Lett Drugs Ther; 2018 Jun; 60(1549):e109. PubMed ID: 29913477
    [No Abstract]   [Full Text] [Related]  

  • 3. U-200 Humalog Insulin Now Available in United States.
    Chabanuk AJ
    Home Healthc Now; 2016 Feb; 34(2):102. PubMed ID: 26835809
    [No Abstract]   [Full Text] [Related]  

  • 4. Humalog (lispro) for type 2 diabetes.
    Esposito K; Capuano A; Giugliano D
    Expert Opin Biol Ther; 2012 Nov; 12(11):1541-50. PubMed ID: 23043233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulins for type 2 diabetes.
    Med Lett Drugs Ther; 2019 May; 61(1571):65-68. PubMed ID: 31169803
    [No Abstract]   [Full Text] [Related]  

  • 6. Expanded table: some available insulins for type 2 diabetes.
    Med Lett Drugs Ther; 2019 May; 61(1571):e73-e77. PubMed ID: 31169807
    [No Abstract]   [Full Text] [Related]  

  • 7. [Humalog® 200 U/ml KwikPen™].
    Scheen AJ
    Rev Med Liege; 2015 Oct; 70(10):527-31. PubMed ID: 26727843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus.
    Niskanen L; Jensen LE; Råstam J; Nygaard-Pedersen L; Erichsen K; Vora JP
    Clin Ther; 2004 Apr; 26(4):531-40. PubMed ID: 15189750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin lispro (Humalog), a novel fast-acting insulin analogue for the treatment of diabetes mellitus: overview of pharmacological and clinical data.
    Hermans MP; Nobels FR; De Leeuw I
    Acta Clin Belg; 1999 Oct; 54(5):233-40. PubMed ID: 10555380
    [No Abstract]   [Full Text] [Related]  

  • 10. Why Do Some Concentrated Insulins Maintain Their Pharmacokinetics/Pharmacodynamics Profile?
    Hood RC
    Diabetes Technol Ther; 2017 Apr; 19(4):203-205. PubMed ID: 28418731
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin lispro (Humalog) in the treatment of diabetes mellitus: overview of belgian clinical data from global studies.
    Bex M; Buysschaert M; De Leeuw I; De Schepper J; Fery F; Hermans MP; Keymeulen B; Lauvaux JP; Letiexhe M; Mathieu C; Nobels FR; Rottiers R; Scheen A; Schmitt H; Van Crombrugge P; Van Gaal L
    Acta Clin Belg; 1999 Oct; 54(5):241-5. PubMed ID: 10555381
    [No Abstract]   [Full Text] [Related]  

  • 12. Photoacoustic imaging reveals mechanisms of rapid-acting insulin formulations dynamics at the injection site.
    Khadria A; Paavola CD; Maslov K; Valenzuela FA; Sperry AE; Cox AL; Cao R; Shi J; Brown-Augsburger PL; Lozano E; Blankenship RL; Majumdar R; Bradley SA; Beals JM; Oladipupo SS; Wang LV
    Mol Metab; 2022 Aug; 62():101522. PubMed ID: 35671972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar pharmacokinetics and pharmacodynamics of rapid-acting insulin lispro products SAR342434 and US- and EU-approved Humalog in subjects with type 1 diabetes.
    Kapitza C; Nowotny I; Lehmann A; Bergmann K; Rotthaeuser B; Nosek L; Becker RHA
    Diabetes Obes Metab; 2017 May; 19(5):622-627. PubMed ID: 27987252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lispro insulin in people with non-alcoholic liver cirrhosis and type 2 diabetes mellitus.
    Gentile S; Guarino G; Strollo F; Romano M; Genovese S; Masarone M; Ceriello A
    Diabetes Res Clin Pract; 2016 Mar; 113():179-86. PubMed ID: 26803356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SAR342434 - an insulin biosimilar for the treatment of type II diabetes.
    Hu J; Wang M; Zhao Y
    Expert Opin Biol Ther; 2018 Nov; 18(11):1107-1112. PubMed ID: 30295083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Biosimilar SAR342434 Insulin Lispro in Adults with Type 2 Diabetes, Also Using Insulin Glargine: SORELLA 2 Study.
    Derwahl KM; Bailey TS; Wernicke-Panten K; Ping L; Pierre S
    Diabetes Technol Ther; 2018 Jan; 20(1):49-58. PubMed ID: 29232162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ultra-rapid lispro (Lyumjev®)].
    Philips JC; Paquot N
    Rev Med Liege; 2021 Jan; 76(1):64-68. PubMed ID: 33443332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.
    Maggs DG; Fineman M; Kornstein J; Burrell T; Schwartz S; Wang Y; Ruggles JA; Kolterman OG; Weyer C
    Diabetes Metab Res Rev; 2004; 20(1):55-60. PubMed ID: 14737746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin analogues: new agents for improving glycemic control.
    White JR; Campbell RK; Hirsch I
    Postgrad Med; 1997 Feb; 101(2):58-60, 63-5, 70. PubMed ID: 9046926
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.